Health Policy PhD Candidate, Harvard University
Jamie Daw is a doctoral candidate in health policy at Harvard University concentrating in evaluative science and statistics. She is a Frank Knox Fellow and a Canadian Institutes for Health Research doctoral scholar.
Jamie is currently working with Laura Hatfield on methodological improvements in difference-in-difference designs that use matching to balance baseline characteristics. Her dissertation research focuses on sources of health coverage for women before and after childbirth. She is also interested in the effects of emerging health insurance designs, including high-deductible health plans and health savings accounts, on health care access and health outcomes. She was a health policy intern at J-PAL North America's Health Care Delivery Initiative.
Jamie holds a Bachelor of Health Sciences (Honours) from McMaster University and an MSc in Population and Public Health specializing in health services and policy research from the University of British Columbia. Prior to her doctoral studies, Jamie worked as a researcher with the UBC Centre for Health Services and Policy Research focusing on pharmaceutical policy and women’s health issues.
Jamie's research has been published in leading health services and policy research journals including CMAJ, Health Policy, Health Affairs, and the Journal of Health Policy, Politics and Law. She has co-authored opinion-editorials for national newspapers, a book chapter, and commissioned reports for government and national think-tanks.
Daw JR, Hatfield LA, Swartz K, Summers BD. 2017. Women In The United States Experience High Rates Of Coverage ‘Churn’ In Months Before And After Childbirth. Health Affairs. 36(4), 598-606. 2017
Edelstein C, Kassam Z, Daw JR, Smith MB, Kelly CR. 2015. The regulation of fecal microbiota transplantation: navigating policy and public health. Clinical Research and Regulatory Affairs. 32 (3), 99-107.
Morgan SG, Law MR, Daw JR, Abraham L, Martin D. 2015. Estimated cost of universal public drug coverage of prescription drugs in Canada. Canadian Medical Association Journal 187: 491-497.
Daw JR, Morgan SG, Collins PA, Abelson J. 2014 Framing incremental expansions to public health insurance programs: the case of Canadian pharmacare. Journal of Health Politics, Policy, and Law 39(2): 295-330.
Morgan SG, Daw JR, Thomson PA. 2014. Pharmaceuticals. In Marchildon GP, Di Matteo L (Eds), Bending the Cost Curve in Health Care: Canada’s Provinces in International Perspective. The Johnson-Shoyama Series on Public Policy. University of Toronto Press: Toronto. ISBN 9781442609754.
Morgan SG, Daw JR, Law MR. Are income-based public drug benefit programs fit for an aging population? Institute for Research on Public Policy Research Study No. 50, 2014.
Morgan SG, Daw JR, Law MR. Rethinking pharmacare in Canada. C.D. Howe Institute Commentary No. 384, 2013.
Puyat J, Daw JR, Morgan SG, Law MR, Cunningham CC, Wong S. 2013. Ethnic disparities in the use of antipsychotics: a systematic review and meta-analysis. Social Psychiatry and Psychiatric Epidemiology 48(12): 1861-72.
Morgan SM, Thomson PT, Daw JR, Friesen MK. 2013. Canadian policy makers’ views on pharmaceutical reimbursement contracts involving confidential discounts from drug manufacturers. Health Policy 112(3): 248-54.
Morgan SM, Friesen MK, Thomson PT, Daw JR. 2013. Use of product listing agreements by provincial drug benefit plans. Healthcare Policy 8(4): 45-55.
Morgan SM, Daw JR, Thomson PA. 2013. International best practices for negotiating ‘reimbursement contracts’ with price rebates from pharmaceutical companies. Health Affairs 32(4): 771-777.
Law MR, Daw JR, Cheng L, Morgan SG. 2013. Growth in private payments for health care by Canadian households. Health Policy 110(2): 141-146.
Daw JR, Morgan SG, Thomson PA, Law MR. 2013. Here today, gone tomorrow: the issue attention cycle and national print media coverage of prescription drug financing in Canada. Health Policy 110(1): 67-75.
Morgan SM, Thomson PT, Daw JR, Friesen MK. 2013. Inter-jurisdictional co-operation on pharmaceutical product listing agreements: lessons from Canada. BMC Health Services Research 13:34.
Morgan SG, Daw JR. 2012. Canadian pharmacare: looking back, looking forward. Healthcare Policy 8(1): 17-25.
Daw JR, Morgan SG. 2012. Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes 2000-2010. Health Policy 104(1): 19-26.
Daw JR, Mintzes B, Law MR, Hanley GE, Morgan SG. 2012. Prescription drug use in pregnancy: a retrospective population-based study in British Columbia, Canada (2001-2006). Clinical Therapeutics 34(1): 239-249.
Daw JR, Hanley GE, Greyson DG, Morgan SG. 2011. Prescription drug use during pregnancy in developed countries: a systematic review. Pharmacoepidemiology and Drug Safety 20(9): 895-902.